"To my mind, all of this public input and engagement made our work sharper and helped us really set priorities and focus on ...

On the final days of her tenure as Federal Trade Commission chair, Lina Khan sits down with WSJ’s Damian Paletta to reflect ...

The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks, ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The Democratic enforcer significantly expanded the agency’s remit; now the new GOP administration will decide how to follow ...

While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...

Only seven working days remain in the Biden administration, but US Federal Trade Commission Chair Lina Khan still hopes to ...

Chair Lina Khan said Tuesday that she hopes her successor in the incoming Trump administration will not cut a “sweetheart” ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

While they didn't support Musk's allegations directly, the feds added weight to his interpretation of antitrust law.

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

including medications to treat heart disease and cancer,” said FTC Chair Lina Khan in a statement Tuesday. Khan added that the FTC should continue investigating the PBMs and "should act swiftly to ...